# 2026年1月25日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 基因型-表型功能整合分析揭示 KCNQ2 相关疾病认知障碍的不同致病机制

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41579097)
**期刊：** Epilepsia
**PMID：** 41579097
**DOI：** 10.1002/epi.70075

### 第一部分 原文与翻译

**英文原标题：** Integrated genotype-phenotype function analysis reveals distinct pathogenic mechanisms for cognitive impairment in KCNQ2-related disorders.

> **英文摘要：**
> OBJECTIVE: Pathogenic variants of KCNQ2 lead to a spectrum of disorders including self-limited familial neonatal-infantile epilepsy (SeL(F)NIE), developmental and epileptic encephalopathies (DEEs), and neurodevelopmental disorders (NDDs) with intellectual disability (ID). This study aimed to delineate the clinical progression and underlying pathogenesis of these disorders. Particularly, we unraveled the role of gain-of-function (GoF) variants in neurodevelopmental impairment. METHODS: We conducted a longitudinal study of a 90-patient Chinese cohort with KCNQ2-related disorders, classified into SeL(F)NIE, DEEs, and NDDs subgroups. Clinical phenotyping was integrated with functional analyses (electrophysiology, biochemistry) of five missense variants in homomeric and heteromeric (with Kv7.3/Kv7.5) channel assemblies. RESULTS: Despite comparable seizure control to SeL(F)NIE (96% vs 100%), the NDDs group exhibited significant cognitive impairment. All deceased patients (8/90) were in the DEEs group. Functional profiling revealed a spectrum from loss-of-function (LoF) to GoF. LoF variants (e.g., S247L in DEEs) were linked to severe epilepsy. Crucially, we identified strong GoF variants (P335A/L in NDDs) in the S6-HelixA domain that confer insensitivity to phosphatidylinositol 4,5-bisphosphate (PIP2) regulation and are associated with a primary neurodevelopmental phenotype, distinct from the severe epileptic phenotype of established voltage-sensing domain (VSD) GoF variants. SIGNIFICANCE: Our integrated clinical and functional analysis showed that the clinical outcome relies on the functional consequence of a KCNQ2 variant (LoF vs GoF) and its behavior in heteromeric complexes, rather than its mere location. We defined a novel class of strong GoF KCNQ2 variants that are mechanistically and phenotypically distinct, highlighting aberrantly enhanced channel function as a key driver of cognitive dysfunction and presenting new targets for precision medicine.

> **中文摘要：**
> 目的：KCNQ2 的致病性变异导致了一系列疾病，包括自限性家族性新生儿-婴儿癫痫 (SeL(F)NIE)、发育性癫痫性脑病 (DEEs) 以及伴有智力障碍 (ID) 的神经发育障碍 (NDDs)。本研究旨在阐明这些疾病的临床进展及其潜在的发病机制。特别是，我们揭示了功能增益型 (GoF) 变异在神经发育障碍中的作用。方法：我们对一个由 90 名中国患者组成的 KCNQ2 相关疾病队列进行了纵向研究，将其分为 SeL(F)NIE、DEEs 和 NDDs 亚组。将临床表型分析与同源和异源（与 Kv7.3/Kv7.5）通道组装体中五个错义变异的功能分析（电生理学、生物化学）相结合。结果：尽管癫痫发作控制率与 SeL(F)NIE 相当（96% vs 100%），但 NDDs 组表现出显著的认知障碍。所有死亡患者（8/90）均属于 DEEs 组。功能分析揭示了从功能缺失 (LoF) 到功能增益 (GoF) 的谱系。LoF 变异（例如 DEEs 中的 S247L）与严重的癫痫有关。至关重要的是，我们在 S6-HelixA 结构域中发现了强 GoF 变异（NDDs 中的 P335A/L），这些变异导致对磷脂酰肌醇 4,5-二磷酸 (PIP2) 调节不敏感，并且与原发性神经发育表型相关，这与已知的电压感受器结构域 (VSD) GoF 变异导致的严重癫痫表型截然不同。意义：我们的综合临床和功能分析表明，临床结局取决于 KCNQ2 变异的功能后果（LoF 与 GoF）及其在异源复合物中的表现，而非仅仅取决于其位置。我们定义了一类新型的强 GoF KCNQ2 变异，它们在机制和表型上都是独特的，强调了异常增强的通道功能是认知功能障碍的关键驱动因素，并为精准医学提供了新的靶点。

### 第二部分 AI 大师评价

本研究通过对 90 名中国患者队列的纵向随访和深度的电生理功能实验，系统地阐明了 KCNQ2 变异的功能改变与临床表型之间的复杂映射关系。研究最核心的发现是识别出一类位于 S6-HelixA 结构域的新型强 GoF 变异，这类变异通过降低 PIP2 敏感性导致原发性认知障碍，而非严重的癫痫发作，在机制上区别于传统的 VSD 区域 GoF 变异。该研究打破了单纯依赖变异位置预测病情的局限，强调了功能分析在精准医学中的决定性作用，为 KCNQ2 相关神经发育障碍的致病机制提供了重要的分子证据。

---

## 2. 儿科癫痫中的移动健康依从性：一项序列多轮次随机对照试验（SMART）的结果

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41579063)
**期刊：** Epilepsia
**PMID：** 41579063
**DOI：** 10.1002/epi.70097

### 第一部分 原文与翻译

**英文原标题：** mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART).

> **英文摘要：**
> OBJECTIVE: Nonadherence to antiseizure medications in pediatric epilepsy affects ~60% of youth. The aim of this multisite two-stage sequential, multiple assignment, randomized trial (SMART) was to evaluate the effectiveness of mHealth intervention strategies for improving adherence in caregivers of young children with epilepsy, particularly those who are underserved. It was hypothesized that participants initially randomized to treatment would exhibit significantly greater improvements in adherence compared to an active control group at the end of stage 1. Secondary outcomes included longitudinal adherence, seizure freedom/severity, and health-related quality of life. METHODS: Participants across four epilepsy centers were recruited (n = 461, mean age = 7.6 ± 3.0 years, 51% males, 62% White non-Hispanic, 71% underserved). Baseline questionnaires were completed, and electronic adherence monitors were provided. Three intervention strategies were embedded in this SMART: (1) active control (mHealth education + automated digital reminders), (2) treatment (mHealth education + automated digital reminders + individualized adherence feedback) in stage 1 continuing in stage 2 regardless of responsiveness in stage 1, and (3) treatment in stage 1 continuing in stage 2 if patient is responsive in stage 1 or augmented by problem-solving if patient is nonresponsive in stage 1. Active intervention was 5 months, with two posttreatment follow-ups. Standard analysis of covariance was conducted for the primary aim. Secondary analyses compared mean change from baseline associated with each intervention strategy. RESULTS: The treatment group had significantly better mean adherence percentage change from baseline to the end of stage 1 compared to the active control group (13.2% vs. 3.1% change, t = 2.82, p = .005, d = .37). Adherence rates declined over time across all SMART strategies. An increased probability of seizure freedom at 6 and 12 months across all SMART strategies was found. SIGNIFICANCE: This pediatric epilepsy SMART trial demonstrated adherence improvements for the treatment group that did not persist over time. Improvements in seizure freedom that were independent of SMART strategy were also identified. mHealth education, automated digital reminders, and individualized adherence feedback appear to have been efficacious.

> **中文摘要：**
> 目的：儿科癫痫中对抗癫痫药物的不依从性影响了约 60% 的青少年。这项多中心、两阶段序列多轮次随机对照试验（SMART）旨在评估移动健康（mHealth）干预策略在提高癫痫幼儿看护者（特别是服务欠缺的人群）依从性方面的有效性。假设在第 1 阶段结束时，最初被随机分配到治疗组的参与者与主动对照组相比，其依从性会有显著更高的改善。次要结局包括纵向依从性、无发作率/严重程度以及与健康相关的生存质量。方法：招募了来自四个癫痫中心的参与者（n = 461，平均年龄 = 7.6 ± 3.0 岁，51% 为男性，62% 为非西班牙裔白人，71% 为服务欠缺人群）。参与者完成了基线问卷调查，并获得了电子依从性监测器。该 SMART 试验嵌入了三种干预策略：（1）主动对照（mHealth 教育 + 自动数字提醒）；（2）第 1 阶段治疗（mHealth 教育 + 自动数字提醒 + 个体化依从性反馈），无论第 1 阶段反应如何，第 2 阶段均继续执行；（3）第 1 阶段治疗，若患者在第 1 阶段有反应则在第 2 阶段继续，若无反应则辅以问题解决法进行增强。主动干预期为 5 个月，并进行了两次治疗后随访。针对主要目标进行了标准协方差分析。次要分析比较了与每种干预策略相关的基线平均变化。结果：与主动对照组相比，治疗组从基线到第 1 阶段结束的平均依从性百分比变化显著更好（13.2% vs. 3.1% 的变化，t = 2.82，p = .005，d = .37）。在所有 SMART 策略中，依从率均随时间推移而下降。研究发现所有 SMART 策略在 6 个月和 12 个月时无发作的概率均有所增加。意义：这项儿科癫痫 SMART 试验表明，治疗组的依从性有所改善，但并未随时间推移而持续。此外，还发现无发作情况的改善与 SMART 策略无关。mHealth 教育、自动数字提醒和个体化依从性反馈似乎是有效的。

### 第二部分 AI 大师评价

本研究采用创新的 SMART 试验设计，严谨地评估了移动健康干预对儿科癫痫依从性的动态影响。研究证明了结合个体化反馈的复合数字干预在短期内对提升看护者依从性的显著优势，且观察到了普遍的临床获益（无发作率提升）。尽管依从性的长期维持仍面临挑战，但该研究为慢性病数字健康干预的优化路径提供了重要的数据支持，特别是在针对医疗资源匮乏人群的精准干预方面具有高度的参考价值。

---

## 3. 儿童癫痫手术历程中的差异：来自国家联盟关于转诊、建议及完成情况的研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41579031)
**期刊：** Epilepsia
**PMID：** 41579031
**DOI：** 10.1002/epi.70060

### 第一部分 原文与翻译

**英文原标题：** Disparities across the pediatric epilepsy surgery journey: Referral, recommendation, and completion from a national consortium.

> **英文摘要：**
> OBJECTIVE: Despite being safe and effective, surgery for pediatric epilepsy is underutilized. Social determinants of health (SDoH) are important to consider when examining this treatment gap. This study examined the potential systemic inequities at three different stages in the journey toward epilepsy surgery across the Pediatric Epilepsy Research Consortium (PERC). METHODS: Any youth in the PERC prospective surgery database (≤18 years) was eligible and included if sociodemographic factors were also available. We examined if there were differences in disparity factors in: (1) referral to Phase I evaluation, (2) offering of surgery, and (3) completion of surgery. RESULTS: Of 1309 patients, the majority were male (53%, p = .04), White (82.2%, p < .001), not Hispanic or Latino (84.3%, p < .001), and privately insured (56.3%, p < .001). Of the youth who were offered surgical treatment (n = 1103, 84.3%), there were no significant differences in race/ethnicity or sex. Those with a structural lesion were more likely to be offered surgery, and historically marginalized youth were more likely to have a lesion. Of patients who completed surgery (n = 927, 84.0%), White patients were 1.88 times (95% confidence interval [CI]: 1.14-3.04) more likely than Black patients to complete surgery (p = .01). SIGNIFICANCE: Youth who began surgery evaluation are not representative of the demographics of those with epilepsy in the United States, with greater representation of White, non-Hispanic male individuals. In addition, youth who began surgery evaluation disproportionally have private insurance. At the next stage of offering surgery, there were no differences based on SDoH. However, there is evidence that underrepresented youth that were magnetic resonance negative were less likely to be referred for surgical workup and that Black youth were less likely to undergo surgery. Therefore, efforts to provide equitable opportunity for all youth with refractory epilepsy should be concentrated at the referral for surgery evaluation point of care; however, additional efforts are also needed at later stages.

> **中文摘要：**
> 【目的】尽管儿童癫痫手术安全有效，但其利用率仍然不足。在研究这一治疗差距时，健康社会决定因素（SDoH）是需要考虑的重要因素。本研究探讨了儿科癫痫研究联盟（PERC）在走向癫痫手术历程中三个不同阶段的潜在系统性不平等。【方法】PERC前瞻性手术数据库中的任何青少年（≤18岁）均符合入组条件，并在具备社会人口学因素数据时纳入研究。我们检查了以下阶段在差异因素上是否存在显著性：(1) 转诊至第一阶段评估；(2) 提供手术建议；(3) 完成手术。【结果】在1309名患者中，大多数为男性（53%，p = .04）、白人（82.2%，p < .001）、非西班牙裔或拉丁裔（84.3%，p < .001）以及拥有私人保险者（56.3%，p < .001）。在获准提供手术治疗的青少年中（n = 1103, 84.3%），种族/民族或性别没有显著差异。具有结构性病变的患者更有可能获得手术机会，且历史上的边缘化青少年更有可能患有此类病变。在完成手术的患者中（n = 927, 84.0%），白人患者完成手术的可能性是黑人患者的1.88倍（95%置信区间 [CI]：1.14-3.04，p = .01）。【意义】开始手术评估的青少年群体并不能代表美国癫痫患者的人口统计学特征，其中白人、非西班牙裔男性个体的代表性更高。此外，开始手术评估的青少年中拥有私人保险的比例也不成比例。在提供手术的下一阶段，未发现基于健康社会决定因素的差异。然而，有证据表明，磁共振成像结果阴性的欠代表群体青少年被转诊进行手术检查的可能性较低，且黑人青少年接受手术的可能性较低。因此，为所有难治性癫痫青少年提供平等机会的努力应集中在手术评估转诊这一环节；此外，在后续阶段也需要额外的努力。

### 第二部分 AI 大师评价

本研究通过对PERC多中心数据的深入分析，系统揭示了美国儿童癫痫手术链路中存在的结构性不平等。研究发现，不平等现象主要集中在医疗资源获取的起点（转诊评估）和终点（手术完成），尤其是白人与私人保险群体在各个环节均表现出显著优势。尽管在“手术建议”阶段表现出了一定的公平性，但黑人患者较低的手术完成率以及MRI阴性患者的转诊障碍凸显了系统性医疗偏见。该研究为优化儿科癫痫手术的准入路径及制定针对性的干预政策提供了重要的循证依据。

---

## 4. 创伤后应激障碍是难治性癫痫特有的，还是慢性病的共同特征？一项与心房颤动和1型糖尿病的比较研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41578875)
**期刊：** Epilepsia
**PMID：** 41578875
**DOI：** 10.1002/epi.70113

### 第一部分 原文与翻译

**英文原标题：** Is posttraumatic stress disorder specific to drug-resistant epilepsy or a common feature of chronic disease? A comparative study with atrial fibrillation and type 1 diabetes.

> **英文摘要：**
> OBJECTIVE: Posttraumatic stress disorder (PTSD) is more prevalent in epilepsy than in the general population. However, it remains unclear whether this association is specific to epilepsy or a broader consequence of experiencing unpredictable acute episodes within chronic diseases. This study aimed to (1) compare PTSD prevalence and severity in patients with drug-resistant epilepsy (DRE) and patients with other chronic episodic diseases, namely, type 1 diabetes (T1D) and drug-resistant atrial fibrillation (AF); and (2) examine psychiatric comorbidities, emotion regulation, and quality of life across groups. METHODS: A total of 122 patients (64 with DRE; 58 with chronic diseases: 30 with AF, 28 with T1D) completed questionnaires assessing PTSD symptoms, trauma exposure, anxiety, depression, dissociation, emotion regulation, and quality of life. Statistical analyses included χ tests, t-tests, analyses of covariance controlling for age, and correlation analyses. RESULTS: PTSD was significantly more prevalent in the DRE group (34.94%) than in the chronic disease group (12.07%; χ = 9.5, p = .004). DRE patients also reported significantly more repeated trauma exposures (54.69% vs. 27.59%, p = .004). Compared to other groups, DRE patients showed higher anxiety (p = .002), depression (p = .002), and dissociation (p < .001), poorer emotion regulation (p = .003), and lower quality of life (p < .001). SIGNIFICANCE: Our findings suggest that the psychiatric burden observed in DRE cannot be solely attributed to chronic episodic disease status. Instead, it may reflect the impact of early and repeated traumatic exposures and their interaction with the neurobiological underpinnings of epilepsy. The strong association between complex trauma, psychiatric comorbidities, and poor quality of life supports the hypothesis of psychoepileptogenesis and calls for integrated trauma-informed care in epilepsy management.

> **中文摘要：**
> 目的：创伤后应激障碍（PTSD）在癫痫患者中的患病率高于普通人群。然而，目前尚不清楚这种关联是癫痫特有的，还是在慢性疾病中经历不可预测的急性发作所带来的更广泛后果。本研究旨在：（1）比较难治性癫痫（DRE）患者与其他慢性发作性疾病患者（即1型糖尿病 [T1D] 和难治性心房颤动 [AF]）的 PTSD 患病率和严重程度；（2）检查各组间的精神共病、情绪调节和生活质量。方法：共计 122 名患者（64 名 DRE 患者；58 名慢性病患者：30 名 AF 患者，28 名 T1D 患者）完成了评估 PTSD 症状、创伤暴露、焦虑、抑郁、解离、情绪调节和生活质量的问卷。统计分析包括卡方检验、t 检验、控制年龄的协方差分析以及相关分析。结果：DRE 组的 PTSD 患病率（34.94%）显著高于慢性病组（12.07%；χ = 9.5，p = .004）。DRE 患者还报告了显著更多的重复创伤暴露（54.69% 对比 27.59%，p = .004）。与其他组相比，DRE 患者表现出更高水平的焦虑（p = .002）、抑郁（p = .002）和解离（p < .001），情绪调节能力更差（p = .003），且生活质量更低（p < .001）。意义：我们的研究结果表明，在 DRE 中观察到的精神负担不能仅仅归因于慢性发作性疾病的状态。相反，它可能反映了早期和重复创伤暴露的影响，及其与癫痫神经生物学基础的相互作用。复杂创伤、精神共病与低生活质量之间的强关联支持了“心理癫痫发生”的假设，并呼吁在癫痫管理中整合创伤知情护理。

### 第二部分 AI 大师评价

本研究通过将难治性癫痫与心房颤动和1型糖尿病进行严谨的对比，揭示了癫痫患者显著较高的PTSD患病率及心理负担，证明其精神共病并非仅由慢性病的“发作性”特征引起。研究发现重复创伤暴露与癫痫之间存在独特的关联，并深度探讨了其与解离症状及情绪调节障碍的关系。该研究提出的“心理癫痫发生”概念极具启发性，尽管受限于横断面设计，但为癫痫临床治疗中引入创伤知情护理提供了强有力的循证依据。

---

## 5. 颅内神经调控在难治性儿童及成人癫痫中的安全性研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41576312)
**期刊：** Neurology
**PMID：** 41576312
**DOI：** 10.1212/WNL.0000000000214626

### 第一部分 原文与翻译

**英文原标题：** Safety of Intracranial Neuromodulation in Drug-Resistant Pediatric and Adult Epilepsy.

> **英文摘要：**
> BACKGROUND AND OBJECTIVES: Intracranial neuromodulation is an established therapy for drug-resistant epilepsy (DRE) in adults. Improving seizure outcomes and expanding its application to pediatric patients remain priorities. Off-label use of 2-lead and 4-lead devices targeting multiple network nodes, combined with varied stimulation parameters, has emerged in pursuit of better outcomes. Although early findings are promising, the safety of these approaches remains underexplored. This study evaluates adverse event (AE) rates associated with different intracranial neuromodulation devices from a single center.
> 
> METHODS: This retrospective study from the Mayo Clinic (Rochester, MN) included patients with DRE who underwent intracranial neuromodulation between August 2004 and December 2024. Demographic data, epilepsy characteristics, treatment indications, procedural details, and AEs were extracted from medical records. AEs are undesirable events associated with implantation and use of the device, regardless of causation. Serious AEs were life threatening or resulted in hospitalization, persistent or significant disability, or death. Patients were classified as children (<13 years), adolescents (13-18 years), or adults (≥19 years).
> 
> RESULTS: A total of 217 patients (108 male patients, 109 female patients; 14 children, 43 adolescents, 160 adults) were analyzed. Devices included 2-lead deep brain stimulation (DBS) (111 patients), 4-lead DBS (51 patients), and responsive neurostimulation (55 patients). Device-related AEs included stimulation-related paresthesia (7.8%), infections (4.1%), asymptomatic intracranial hemorrhage (ICH) (3.7%), bowstring effect (extension wire tethering that limits neck mobility) (3.2%), operation-related focal weakness (2.3%), wound dehiscence (1.8%), device migration (1.8%), lead malposition (1.4%), lead fracture (1.4%), lead migration (0.5%), extensor wire fracture (0.5%), extrusion (0.5%), and symptomatic ICH (0.5%). While no significant difference in overall AE rates was found between sexes, device explantation was significantly higher in female patients than in male patients (11.9% [13/109] vs 1.9% [2/108],  = 0.006). Children and patients with 4-lead DBS had a higher risk of developing bowstringing compared with other age groups and device types.
> 
> DISCUSSION: Intracranial neuromodulation demonstrated an acceptable safety profile across sexes and age groups. However, children and patients with 4-lead DBS systems were at increased risk of the bowstring effect. These findings highlight the need for tailored device design and surgical strategies to optimize safety, particularly in pediatric populations.

> **中文摘要：**
> 背景与目的：颅内神经调控是治疗成人难治性癫痫（DRE）的一种成熟疗法。改善癫痫发作结局并将其应用扩展至儿科患者仍是当务之急。为了追求更好的预后，针对多个网络节点的2导联和4导联设备的超说明书使用，结合多样的刺激参数，已经开始兴起。尽管早期发现前景广阔，但这些方法的安全性仍未得到充分探索。本研究评估了来自单一中心的、与不同颅内神经调控设备相关的不良事件（AE）发生率。
> 
> 方法：这项来自梅奥医学中心（明尼苏达州罗切斯特市）的回顾性研究纳入了在2004年8月至2024年12月期间接受颅内神经调控治疗的DRE患者。从医疗记录中提取了人口统计学数据、癫痫特征、治疗指征、手术细节和不良事件（AE）。AE是指与设备植入和使用相关的、无论因果关系如何的不良事件。严重不良事件（SAE）指危及生命或导致住院、持续或显著残疾或死亡的事件。患者被分类为儿童（<13岁）、青少年（13-18岁）或成人（≥19岁）。
> 
> 结果：共对217名患者（108名男性，109名女性；14名儿童，43名青少年，160名成人）进行了分析。设备包括2导联深部脑刺激（DBS）（111名患者）、4导联DBS（51名患者）和反应性神经刺激（55名患者）。设备相关的不良事件包括：刺激相关的感觉异常（7.8%）、感染（4.1%）、无症状颅内出血（ICH）（3.7%）、弓弦效应（由于延长线限制颈部活动的系留作用）（3.2%）、手术相关的局灶性无力（2.3%）、伤口裂开（1.8%）、设备迁移（1.8%）、导联错位（1.4%）、导联断裂（1.4%）、导联迁移（0.5%）、延长线断裂（0.5%）、挤压出（0.5%）和症状性颅内出血（0.5%）。虽然男女之间的总AE发生率没有显著差异，但女性患者的设备移除率显著高于男性（11.9% [13/109] 对比 1.9% [2/108]，p = 0.006）。与其他年龄组和设备类型相比，儿童和使用4导联DBS的患者发生弓弦效应的风险更高。
> 
> 讨论：颅内神经调控在不同性别和年龄组中显示出可接受的安全性。然而，儿童和使用4导联DBS系统的患者发生弓弦效应的风险增加。这些发现强调了定制化设备设计和手术策略的必要性，以优化安全性，特别是在儿科人群中。

### 第二部分 AI 大师评价

本研究通过梅奥医学中心长达20年的大样本回顾性分析，系统性地评估了颅内神经调控在全年龄段癫痫患者中的安全性。研究证实了该技术的整体安全性，并敏锐地捕捉到了儿童及4导联DBS患者中特有的“弓弦效应”风险，以及女性患者中较高的设备移除率。这些发现不仅为临床医生在术前风险沟通和术后随访提供了精准的数据支持，也为未来儿科专用神经调控设备的设计改良和手术路径优化指明了方向。

---

## 6. 脊髓膜膨出修复术后新生儿的睡眠呼吸障碍研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41570998)
**期刊：** Pediatrics
**PMID：** 41570998
**DOI：** 10.1542/peds.2025-073458

### 第一部分 原文与翻译

**英文原标题：** Sleep-Disordered Breathing in Newborns After Myelomeningocele Repair.

> **英文摘要：**
> BACKGROUND & OBJECTIVE: Sleep-disordered breathing (SDB) may be a remediable contributor to abnormal cognitive outcomes for children with myelomeningocele. We investigated the frequency of SDB among neonates with fetal vs postnatal myelomeningocele repair. METHODS: In this nine-center, prospective, observational study, neonates with myelomeningocele born at more than 30 weeks gestational age underwent a 10-hour bedside polysomnogram at at least 35 weeks postmenstrual age, before hospital discharge. The primary outcome was SDB severity, reflected by the apnea-hypopnea index (AHI; number of respiratory events per hour of sleep). Decisions regarding surgical timing (fetal vs postnatal), technique (open fetal vs fetoscopic approach), and SDB treatment were made by the clinical teams. RESULTS: Among 173 infants, 92/173 (53%) had SDB (median AHI 22.5, IQR 12.2-44.2). In unadjusted analysis, AHI was higher among the 90 neonates with fetal repair vs 83 with postnatal surgery (median 29, IQR 14-49, vs 19, IQR 10-36, P = .008). In propensity-adjusted multivariable models, prematurity was independently associated with AHI, whereas surgical timing (fetal vs postnatal) was not. Hindbrain herniation, myelomeningocele level, and clinical need for ventriculoperitoneal shunt did not predict AHI in adjusted models. Supplemental oxygen was commonly prescribed, for 44% of fetal vs 39% of postnatal myelomeningocele repair infants (P = .5). CONCLUSIONS: SDB affects more than half of neonates with myelomeningocele. The higher AHI after fetal surgery could stem from the elevated incidence of prematurity in this group. As SDB is treatable and has a potential impact on neurodevelopment, routine screening could become an integral part of a strategy to optimize long-term medical and neurodevelopmental outcomes.

> **中文摘要：**
> 背景与目的：睡眠呼吸障碍（SDB）可能是导致脊髓膜膨出患儿认知结局异常的一个可纠正因素。本研究调查了接受胎儿期修复与出生后修复的脊髓膜膨出新生儿中SDB的发生频率。方法：在这项由九个中心开展的前瞻性观察性研究中，胎龄超过30周的脊髓膜膨出新生儿在出院前、经期后年龄至少为35周时接受了10小时的床旁多项睡眠图检查。主要结局是SDB的严重程度，由呼吸暂停低通气指数（AHI；每小时睡眠中的呼吸事件数）反映。关于手术时机（胎儿期对比出生后）、手术技术（开放式胎儿手术对比胎儿镜手术）以及SDB治疗的决策由临床团队做出。结果：在173名婴儿中，92/173名（53%）患有SDB（AHI中位数为22.5，四分位距[IQR]为12.2-44.2）。在未调整的分析中，90名接受胎儿期修复的新生儿其AHI高于83名接受出生后手术的新生儿（中位数分别为29 [IQR 14-49] 和 19 [IQR 10-36]，P = .008）。在倾向性调整的多变量模型中，早产与AHI独立相关，而手术时机（胎儿期对比出生后）则无关。在调整后的模型中，后脑疝、脊髓膜膨出节段以及脑室腹腔分流术的临床需求并不能预测AHI。补充氧气是常用的干预手段，接受胎儿期修复的婴儿中有44%使用，而出生后修复的婴儿中有39%使用（P = .5）。结论：SDB影响了超过一半的脊髓膜膨出新生儿。胎儿手术后较高的AHI可能源于该组中早产发生率的升高。由于SDB是可治疗的，且对神经发育具有潜在影响，常规筛查可能成为优化长期医疗和神经发育结局策略中的重要组成部分。

### 第二部分 AI 大师评价

这项多中心前瞻性观察研究揭示了脊髓膜膨出患儿在新生儿期SDB的高发病率（53%），具有显著的临床意义。研究深入探讨了手术时机对呼吸指标的影响，发现虽然胎儿手术组AHI更高，但调整后显示早产才是核心风险因素。该研究不仅明确了早产在病情进展中的作用，还强调了早期筛查和干预对改善患儿长期神经发育预后的潜在价值。

---

速递结束，祝您工作愉快！